Phenylacetic acid

We are Phenylacetic acid CAS:103-82-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Phenylacetic acid
CAS.NO:103-82-2
Synonyms:Phenylacetic acid
benzylcarboxylic acid
phenylethanoic acid
ω-Phenylacetic acid
Benzeneacetic acid
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 265.5±0.0 °C at 760 mmHg
Melting Point 76-78 °C(lit.)
Molecular Formula C8H8O2
Molecular Weight 136.148
Flash Point 156.2±13.9 °C
Vapour density ~4 (vs air)
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.552
 
Specification:
Appearance:White crystal
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Phenthoate acid(CAS:13376-78-8)、Benalaxy(CAS:71626-11-4)、Diphacinone(CAS:82-66-6) and Chlorophacinone(CAS:3691-35-8)..

Phenylacetic acid


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.3-NITRO-5-(TRIFLUOROMETHYL)BENZOIC ACID CAS:328-80-3 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.Ácido 3,4-difluoro-2-metilbenzoico CAS:157652-31-8 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.942-01-8 This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.

Related Products
Product Name
6-Bromo-5-chloropyridin-2-amine View Details
Glyoxylic Acid View Details
perfluorooctanoic acid View Details
4-Pyridinylboronic Acid manufacturer 3-Fluoro-5-nitrotoluene manufacturer 2,3-Dimethylphenyl isothiocyanate manufacturer N,4-diphenylaniline manufacturer 3-bromofluoren-9-one manufacturer